The HMGI proteins (HMGI, HMGY and HMGI-C) have an important role in the chromatin organization and interact with dierent transcriptional factors. The HMGI genes are expressed at very low levels in normal adult tissues, whereas they are very abundant during embryonic development and in several experimental and human tumours. In order to isolate proteins interacting with the HMGI(Y) proteins, a yeast two-hybrid screening was performed using the HMGI(Y) protein as bait. This analysis led to the isolation of homeodomaininteracting protein kinase-2 (HIPK2), a serine/threonine nuclear kinase. HIPK2 co-immunoprecipitates with the HMGI(Y) protein in 293T cells. The interaction between HIPK2 and HMGI(Y) occurs through the PEST domain of HIPK2 and it is direct because in vitro translated HIPK2 binds HMGI(Y). We also show that HIPK2 is able to phosphorylate the HMGI(Y) protein by an in vitro kinase assay. In order to understand a possible role of HIPK2 gene in cell growth we performed a colony assay which showed an impressive HIPK2 inhibitory eect on normal thyroid cells. Flow cytometric analysis would indicate the block of cell growth at the G2/M phase of the cell cycle. Since normal thyroid cells do not express detectable HMGI(Y) protein levels, we assume that the HIPK2 inhibitory eect is independent from the interaction with the HMGI(Y) protein. Oncogene (2001) 20, 6132 ± 6141.
Introduction
HMGI, HMGY and HMGI-C proteins belong to the High Mobility Group I protein family. The ®rst two proteins are encoded by the same gene, i.e. HMGI(Y), through alternative splicing (Johnson et al., 1988 (Johnson et al., , 1989 , while HMGI-C is the product of a dierent gene (Man®oletti et al., 1991) . These nonhistone nuclear proteins are thought to aect transcription by acting as architectural proteins (Fashena et al., 1992; Grosschedl et al., 1994; Lovell-Badge, 1995) .
HMGI protein levels are high during embryogenesis Chiappetta et al., 1996) , and low in normal adult tissues. Rearrangements of the HMGI-C and the HMGI(Y) genes play an important role in the generation of benign and malignant tumours: in fact, they have been found rearranged in human benign tumours of mesenchymal origin carrying a chromosomal translocation involving regions 12q13-14 and 6p21, respectively Schoenmakers et al., 1995; Tkachenko et al., 1997; Xiao et al., 1997) . Moreover, transgenic mice carrying a rearranged HMGI-C gene develop pelvic and abdominal lipomatosis (Battista et al., 1999) .
HMGI gene overexpression is a constant feature of malignant neoplasias. Indeed, elevated expression of HMGI proteins correlates with the appearance of a malignant phenotype in rat thyroid transformed cells and in thyroid and skin experimental tumours (Giancotti et al., 1985 (Giancotti et al., , 1987 (Giancotti et al., , 1989 . Similarly, HMGI(Y) protein levels are high in such human carcinomas as thyroid (Chiappetta et al., 1995 (Chiappetta et al., , 1998 , colon Abe et al., 1999; Chiappetta et al., 2001) , prostate (Tamimi et al., 1993) , pancreas (Abe et al., 2000) and cervix (Bandiera et al., 1998) , but not in their normal counterparts. A high level of HMGI expression is required for expression of the malignant phenotype. Indeed, blockage of HMGI synthesis prevents rat thyroid cell transformation by murine transforming retroviruses .
Like the other members of the HMG family, HMGI proteins have no intrinsic transcriptional activity (Grosschedl et al., 1994) . Their DNA binding domains contain the`AT-hooks' motifs and thus recognize the narrow minor groove of (A+T)-rich DNA region, that are found in many gene promoters. Given the scarce speci®city for DNA exerted by HMGI proteins, it is not clear how these abundant proteins selectively regulate the expression of several groups of genes. Studies with HMGI(Y) suggest that this`selective' speci®city involves protein ± protein interactions with speci®c transcriptional factors (Du and Maniatis, 1994; Falvo et al., 1995; Grosschedl et al., 1994; Maniatis, 1992, 1995) . Identi®cation of proteins that interact with HMGI(Y) may help to clarify the latter's biological functions. The aim of this study was to use yeast two-hybrid screening to identify molecular partners of HMGI(Y) proteins.
Here we report the isolation of homeodomaininteracting protein kinase-2 (HIPK2), a newly identi®ed serine/threonine nuclear kinase (Kim et al., 1998) able to phisically interact with HMGI(Y). HIPK2 gene has a strong inhibitory eect on dierent cell lines which is indipendent from the interaction with the HMGI(Y) proteins and is suppressed by the impairment of the catalytic function.
Results

Two-hybrid screening for the isolation of the HMGI(Y)-interacting proteins: isolation of HIPK2 protein
The yeast two-hybrid system was used to identify proteins that interact with HMGI(Y). A fusion between LexA protein and the entire HMG-Y protein (LexA/HMG-Y) was used as a bait to screen a mouse embryo cDNA library fused to the VP16 activation domain (Vojtek and Hollenberg, 1995) . Three positive clones (B4, B6 and C21) that interacted speci®cally and reproducibly (see Materials and methods) with HMG-Y shared identical cDNA inserts, and were further characterized. Sequence analysis of the 333-bp insert of clone B4 revealed an open reading frame (ORF). The predicted 111-amino acid sequence derived from this ORF was used to search data bases using the BLAST program and was found to be identical with part of the coding sequence of HIPK2, a member of a novel family of serine/threonine nuclear kinases (Kim et al., 1998) . Using clone B4 insert as a probe, a mouse embryo cDNA library was screened to isolate the fulllength cDNA. One positive clone contained an ORF of 3570 nucleotides that encoded a polypeptide of 1189 amino acids, leaving 104 and 350 nucleotides respectively of 5' and 3' untranslated sequences. The translated product exactly matched the HIPK2 protein.
Sequence alignment showed that the B4 insert corresponded to the region from amino acids 787 ± 897 of the mouse HIPK2. As shown in Figure 1a , this region includes a nuclear localization signal (amino acids 821 ± 827, NLS) and overlaps with a nuclear speckle retention signal (amino acids 860 ± 967, SRS; Hedley et al., 1995) and with a PEST sequence (amino acids 839 ± 934). This region, which is rich in proline, glutamic acid, serine and threonine, confers susceptibility to rapid intracellular proteolysis (Rogers et al., 1986) . The HMG-Y interacting domain (HMG-Y ID) is on the C-terminal side of an HIPK2 region (amino acids 787 ± 897) that is involved in the interaction with the products of homeodomain transcription factor (Kim et al., 1998) .
HMGI(Y) physically interacts with HIPK2
To investigate whether HIPK2 and HMG-Y are physically associated in vivo, 293T cells were transfected with pCMV/HMG-Y and pHA-tagged/333 bp-HIPK2 expression vectors matching the B4 clone isolated by the two-hybrid screening. Protein complexes containing HMG-Y were immunoprecipitated with the anti-HMG-Y polyclonal antibodies, and analysed by immunoblotting with the HA monoclonal antibody. The HIPK2 protein was present in immunoprecipitates from cells transfected with both pCMV/ HMG-Y and pHA-tagged/333 bp-HIPK2 expression plasmids and not in those expressing HMG-Y alone. This demonstrates that HMG-Y and HIPK2 formed complexes in vivo (Figure 1b ). To evaluate further the HMGI(Y)/HIPK2 interaction, full-length HIPK2 labelled with 35 S-methionine produced by translation in reticulocyte extracts was allowed to bind to HMG-Y fused to glutathione S-transferase (GST); the complex was immobilized on a glutathione-Sepharose matrix and the bound proteins were analysed by SDS ± PAGE. The input HIPK2 protein was recovered as complexes with HMG-Y (Figure 1c ), therefore we concluded that the two proteins interact and that the interaction seems to be direct. The speci®city of the interaction was con®rmed by the observation that HIPK2 did not adhere to GST resin devoid of HMG-Y under identical conditions ( Figure 1c ).
Mapping of the HMGI(Y) region responsible for binding to HIPK2
To map the HMGI(Y) region required for binding to HIPK2, we generated a series of progressive carboxyterminal deletions of the HMGI(Y) gene (Figure 2a) . The resulting cDNAs were tagged with the in¯uenza HA epitope into the pCEFL-HA expression vector. These mutants were tested for their interaction in vivo with HIPK2 in co-immunoprecipitation assays. Each HMGI(Y) plasmid was transiently transfected in 293T cells together with a pFLAG-HIPK2 expressing vector. Forty-eight hours after transfection, cells were harvested and protein extracts were immunoprecipitated with anti-FLAG antibodies. Immunoblotting analysis with anti-HA antibody showed that approximately equal amounts of wild-type and mutant HMG-Y proteins were produced (data not shown). Immunoblotting with anti-FLAG antibody con®rmed that the HIPK2 protein levels in each transfection were the same (not shown). As shown in Figure 2b HIPK2 is able to phosphorylate HMGI(Y) protein HIPK2 phosphorylates NK homeodomain transcription factors in vitro (Kim et al., 1998) . To set up a HIPK2 kinase assay, FLAG-tagged HIPK2 produced in 293T cells was subjected to immune complex kinase assay using myelin basic protein (MBP) as substrate. As shown in Figure 3a , FLAG-HIPK2 eciently phosphorylated MBP. Conversely, the mutant in the ATP-binding site K221R/HIPK2 was catalytically inactive (Figure 3a) . The expression levels of the wild-type HIPK2 and of the FLAG-tagged HIPK2 mutant are shown in Figure 4b . Moreover, the HIPK2 protein undergoes autophosphorylation (see Figure 3c ), indicating that the protein itself could be regulated by phosphorylation. To further characterize the phosphorylation of the HIPK2 protein, we subjected the anti-HIPK2 immunoprecipitates to Western blotting with anti-phosphotyrosine antibodies. The results demonstrate that HIPK2 had high levels of constitutive tyrosine phosphorylation that was not abrogated by the mutation of the catalytic residue ( Figure 3d ). Consequently, tyrosine phosphorylation of the HIPK2 kinase does not re¯ect its intrinsic kinase activity, and it could be mediated by a dierent kinase.
We next investigated if HIPK2 phosphorylates GST/ HMG-Y in vitro. In this case, the anti-FLAG immunoprecipitates from pFLAG-HIPK2-transfected 293T cells were incubated with protein GST or GST/ HMG-Y. As shown in Figure 3e , GST/HMG-Y, but not GST alone, was phosphorylated by HIPK2. This phosphorylation was mediated by HIPK2 since it was not detected in kinase-dead HIPK2 immunoprecipitates ( Figure 3e ). 
HIPK2 expression inhibits cell growth
As HMGI proteins have been implicated in cell proliferation , we investigated whether overexpression of HIPK2 aects cell growth. First, we performed a colony assay experiment by transfecting HIPK2 in a sense and antisense orientation in normal thyroid epithelial PC Cl 3 cells (see Table 1 ) and pre-adipocytic 3T3-L1 cells (data not shown). In both cases, after G418 selection, the number and growth of the colonies obtained by transfection with the pCEFL-HA/HIPK2 sense plasmid decreased dramatically compared to antisense or empty vector (see Figure 4 for transfected-PC Cl 3; Table 1 ). These results show that HIPK2 inhibits cell growth. Conversely, the expression of K221R/HIPK2 in PC Cl 3 cells did not reduce the number of colonies compared with the empty vector ( Table 1 ), indicating that the kinase activity is involved in the HIPK2-induced inhibition of cell growth. We also transfected an expression plasmid containing only the HMG-Y interaction domain (HMG-Y ID) of HIPK2 (pCEFL-HA/333 bp-HIPK2) alone or in combination with the pCEFL-HA/HIPK2 sense plasmid. The HMG-Y ID contains the NLS and SRS necessary to enter the nucleus and the nuclear speckles. We found that the HMG-Y ID construct alone did not aect cell growth compared to the empty vector. More interestingly, the co-expression of this construct with the full-length HIPK2 largely abolished the ability of HIPK2 to inhibit cell growth (see Table 1 ). These results suggest that HIPK2 is a negative regulator of cell proliferation and that its interaction with HMGI(Y) is important for this activity.
Subsequently, we investigated the mechanism whereby HIPK2 inhibited cell growth by cyto¯uorimetry. As a model system we used the 293T and the PC Cl 3 cells. They were transiently transfected with a pFLAG-HIPK2 expressing vector along with a plasmid encoding the farnesylated eukaryotic green¯uorescence protein (fEGFP), that allowed identi®cation of transfected cells, collected after 36 and 48 h and ®xed with ethanol. The results are summarized in Figure 5 . Transfection eciency was approximately 70% in the case of 293T cells and 30% in the case of PC Cl 3 cells. Cyto¯uorimetric analysis showed that HIPK2 did not induce signi®cant apoptosis both in 293T and in PC Cl 3 cells. In fact, the fraction of subG1 population of green HIPK2-transfected cells was similar to that of non green transfected cells or that of control vectortransfected cells. Conversely, it appears that HIPK2 modi®ed cell cycle distribution of both 293T and PC Cl 3 cells. As control, we have used p27, a Cdk inhibitor of cell cycle (Polyak et al., 1994) . HIPK2 induced a twofold accumulation of cells in the G2/M phase of the cell cycle both in 293T and PC Cl 3 cells (Figure 5a,b) . The relative inhibitory activity of HIPK2 was also measured as inhibition per cent of BrdU incorporation (IP) calculated as the percentage of transfected cells (green) that incorporated BrdU, relative to the percentage of nontransfected cells (not green) that incorporated BrdU. BrdU incorporation was reduced by the transfection of HIPK2 (IP: about 50% for 293T and about 40% for PC Cl 3 cells, respectively) ( Figure  5c ). These results were further supported by the ®nding that HIPK2 expression induced accumulation of cyclin B1, which is involved in the exit from G2-M, but not of cyclin A and cyclin D3, as shown by Western blot experiments in Figure 6 .
Discussion
In an attempt to understand the function of chromatinassociated HMGI(Y) proteins, we looked for HMGI(Y) interacting proteins using yeast two-hybrid screening. The search revealed the HIPK2 protein, a member of a recently identi®ed family of nuclear protein kinases that interact with homeodomain transcription factors (Kim et al., 1998) and that are well conserved in various organisms. HIPK2 acts as a transcriptional co-repressor of homeoproteins and contains multiple functional domains: an interaction Protein extracts (500 mg) were immunoprecipitated with the anti-FLAG antibody, and probed with the anti-HA antibody domain for homeoproteins, a co-repressor domain, a PEST sequence, a YH domain in the COOH-terminal and a protein kinase catalytic domain in the NH2-terminal (Kim et al., 1998) . Interestingly, HIPK2 localizes to nuclear speckles which are distinct from the speckles containing splicing factors. HIPK2 is a component of a co-repressor complex containing Groucho and a histone deacetylase complex . It also acts as co-repressor of NK-3 homeodomain transcription factors . The interaction of HIPK2 with these proteins occurs through the homeoprotein interaction domain.
Here we show that the HIPK2 protein co-immunoprecipitates with HMGI(Y) and that the second AThook domain of HMG-Y is essential for this interaction in 293T cells. Moreover, unlike the cases cited above, this interaction occurs through the PEST region of HIPK2. We also found that HIPK2 and HMGI(Y) colocalize in nuclear speckles (data not shown). The interaction seems to be direct since the in vitro translated HIPK2 protein binds HMG-Y.
HMGI proteins have been implicated in cell proliferation. In fact, disruption of the HMGI-C gene results in a mouse pygmy phenotype associated with a decreased growth rate of the embryonic ®broblasts originating from these mice , whereas transgenic mice carrying an activated form of HMGI-C showed an opposite phenotype (Battista et al., 1999) . These ®ndings prompted us to investigate the role of HIPK2 in cell growth. Here we show that HIPK2 exerts a potent inhibitory eect on normal cell lines. The catalytic domain is essential for inhibition, as shown by the fact that a mutation impairing the serinethreonine kinase activity blocked the ability of HIPK2 to induce cell growth arrest. We also demonstrate that a deletion construct of the HIPK2 gene, deprived of the catalytic domain and of the YH domain, prevented the inhibitory eect of HIPK2. In fact, pCEFL-HA/ 333 bp-HIPK2 acts as a negative dominant by increasing the number of colonies obtained by pCEFL-HA/HIPK2 cell transfection in a dose-dependent manner. However, since PC Cl 3 cells do not appear to express HMGI(Y) (Giancotti et al., 1989; Berlingieri et al., 1995) , our results indicate that the growth inhibitory eect of HIPK2 does not depend on the interaction with HMG-Y. Moreover, the overexpression of HMGI(Y) does not seem to impair the growth inhibitory eect of HIPK2. In fact, the overexpression of HIPK2 reduces the number of colonies in a colony assay also on a human thyroid (Chiappetta et al., 1995) . There is, also, another evidence that some of the HIPK2 functions are independent from HMGI(Y) expression. In fact, we have demonstrated, by Northern blotting, that HIPK2 is expressed at 17 d.p.c. in mouse embryos (Pierantoni, manuscript in preparation), while HMGI(Y) is expressed at high levels in all embryonic stages .
It is interesting to observe that, even though it has been demonstrated that HIPK2 interacts with apoptotic proteins (Li et al., 2000; Rochat-Steiner et al., 2000) , HIPK2 overexpression did not induce apoptotic eect on PC Cl 3 and 293T cells.
HIPK2 binds directly PATZ (POZ-AT hook-zinc ®nger protein, Fedele et al., 2000) as well as RNF4 (Ring-®nger protein, Chiariotti et al., 1998) (our unpublished results), which, in turn, binds the HMGI(Y) and PATZ proteins (Fedele et al., 2000) . Therefore, it is conceivable that RNF4, HIPK2, PATZ and HMGI(Y) are members of a multimeric complex. Since HMGI(Y) is an architectural component of chromatin, we may speculate that HMGI(Y) can assembly these proteins on promoters and enhancers of several genes, and thus modulate gene expression. Interestingly, all these proteins have been reported to localize in nuclear speckles. We do not know the functional role of this complex interaction yet. We can only speculate that since RNF4 is a transcriptional activator and PATZ is a repressor (Fedele et al., 2000) , they may form a multimeric complex that is involved in transcriptional regulation and that the activity of this complex depends on the relative abundance or phosphorylation state of each component.
Therefore, although the role of the HIPK2/ HMGI(Y) interaction remains to be elucidated, the growth inhibition induced by HIPK2 suggests that this protein complex functions as a candidate tumour suppressor. The reduced expression of HIPK2 in a signi®cant number of breast and thyroid carcinomas (data not shown) and its localization on chromosome 7q32-33 (Pierantoni, manuscript in preparation), a region showing loss of heterozygosity in some human neoplasms, support this suggestion. The colony assay was performed as described in Materials and methods. Colonies were counted and the average of three duplicate experiments is reported
Materials and methods
Yeast two-hybrid screening
The pLexA/HMG-Y plasmid was constructed by inserting the entire HMG-Y coding sequence, ampli®ed with oligonucleotides containing EcoRI and BamHI restriction sites (forward-HMG 5'-TTAAGAATTCAGCGAGTCGGGCTCAAAG-3'; reverse-HMG 5'-AATTGGATCCTGCGAGTGGTGATCA-CTG-3'), into the pBTM116 plasmid (Vojtek and Hollenberg, 1995) . The yeast reporter strain L40, which contains the reporter genes LacZ and HIS3 downstream of the binding sequences for LexA, was sequentially transformed with the pLexA/HMG-Y plasmid and with a mouse embryo cDNA library (Clontech) in vector plasmid pVP16, using the lithium acetate method and subsequently treated as described (Vojtek and Hollenberg, 1995) . Double transformants were plated on synthetic medium lacking histidine, leucine, tryptophan, uracil and lysine. The plates were incubated at 308C for 3 days. His + colonies were patched on selective plates and assayed for b-galactosidase activity by a ®lter assay (Vojtek and Hollenberg, 1995) . pVP16 library plasmids were then rescued from His + /LacZ + colonies and tested for speci®city by cotransformation into L40 with pLexA-HMGI(Y), pLexA-galectin1, pLexA-Rab7 and pLexA-ras. The cDNA inserts from speci®c clones were sequenced using the dideoxytermination method (Sanger et al., 1977) . Nucleotide and protein sequence analysis and comparisons were carried out with the BLAST (Altschul et al., 1990) and PROSITE (Appel et al., 1994) programs.
Screening of cDNA library
A mouse 15-day embryo cDNA library in lgt11 was purchased from Clontech. A total of 2610 6 recombinant clones were screened by an in situ plaque hybridization technique (Sambrook et al., 1989) . The 333-bp insert of pVP16-HIPK2 (clone B4) was labelled by the random priming procedure (Feinberg and Vogelstein, 1983 ) and used as a probe. Hybridizations were carried out at 608C, and ®lters were washed under high-stringency (26SSC, 0.1% SDS at 428C). Phage DNA was isolated by a small-scale puri®cation procedure (Sambrook et al., 1989) . The longest cDNA insert (4024 bp) was subcloned in the pGem3Z plasmid (Promega), i.e. pGem3Z-HIPK2. Sequence analysis was performed with the dideoxy-termination procedure (Sanger et al., 1977) .
Construction of fusion genes and expression plasmids
To construct the HMG-Y expression plasmid (pCMV/HMG-Y), the full length HMG-Y cDNA was subcloned into the Figure 6 Expression of cyclins in pFLAG and pFLAG-HIPK2 transfected 293T cells. After 36 and 48 h, whole-cell lysates were prepared and separated by SDS ± PAGE. The ®lters were then probed with the antibodies against cyclin B1, cyclin A and cyclin D3. Anti g-tubulin was used to equalize the amount of proteins loaded HindIII site of the expression vector pRc/CMV (Invitrogen) containing the gene for resistance to G418. Hemagglutinin (pHA)-tagged HIPK2 expression plasmids containing the entire (in sense and antisense orientation) and the 333-bp fragment (HMG-Y ID) of the HIPK2 coding sequence were obtained by ampli®cation and subcloning into the pCEFL-HA (gift of Dr S Gutkind) expression vector. To construct the glutathione S-transferase (GST) fusion genes, the entire HMG-Y coding sequence was ampli®ed by PCR with pairs of primers linked to restriction sites (EcoRI and BamHI), and cloned in the pGEX-2T plasmid (Promega) (pGST/HMG-Y). Plasmid pFLAG-HIPK2 containing the entire HIPK2 coding sequence fused to FLAG epitope was obtained by sequential cloning of the following HIPK2 fragments: from nucleotide 17 to 1507 was cloned by PCR and subsequent digestion (EcoRI-HIPK2 5'-AATTGAATTCTGCCTCACATGTG-CAAGTTTTC-3' and ClaI-HIPK2 5'-AATTATCGATGGT-CAGCATCTTCTTTAACAGG-3'); from nucleotide 1507 to 3149 and from nucleotide 3150 ± 4024 were cloned by digestion of pGem3Z-HIPK2 with ClaI/SalI and SalI/Xba respectively. To obtain HIPK2 (K7), a kinase-dead HIPK2 mutant lacking the catalytic ATP-binding site, the lysine residue of HIPK2 corresponding to lysine 221 of wild-type HIPK2 was replaced with an arginine by recombinant PCR, in the pFLAG and in the pCEFL-HA vectors. pHemagglutinin (pHA)-tagged HMG-Y expression plasmids containing the entire and various portions of the HMG-Y coding sequence were ampli®ed and inserted into the pCEFL-HA espression vector: pHA-Y (amino acids 1 ± 96) is constituted by the entire coding sequence; pHA-Y/T is constituted by the ®rst 79 amino acids including the three AT-hook domains; pHA-Y/1 ± 63 is constituted by the ®rst 63 amino acids including the ®rst two AT-hook domains and the region between the second and the third AT-hook domain; pHA-Y/ 1 ± 53 is constituted by the ®rst 53 amino acids including the ®rst two AT-hook domains; pHA-Y/1 ± 43 is constituted by the ®rst 43 amino acids is constituted by the ®rst AT-hook domain and the region between the ®rst and the second AThook domain. The p27 construct is described elsewhere (Baldassarre et al., 1999) . The fEGFP was purchased from Clontech (Clontech Inc.).
Bacterial expression, in vitro translation and protein-protein binding
Stationary phase cultures of E. coli BL21 cells transformed with the pGEX-2T or pGST/HMG-Y plasmid were diluted 5 ml to 400 ml in LB with ampicillin (100 mg/ml), grown at 308C to an OD 600 of 0.6 and induced with 0.1 mM IPTG. After an additional 2 h at 308C, the cultures were harvested and resuspended in 10 ml of cold phosphate-buered saline (PBS: 140 mM NaCl, 20 mM sodium phosphate (pH 7.4)), 1 mM phenylmethylsulfonyl¯uoride (PMSF) and protease inhibitors (Boehringer). The cells were broken by French Press. The lysate was rocked at 48C for 20 min with Triton X-100 to 1% and clari®ed by centrifugation at 12 000 r.p.m. for 10 min at 48C. The pGem3Z-HIPK2 plasmid containing the entire mouse HIPK2 cDNA was used in an in vitro transcription and translation assay using the TnT SP6-T7-coupled reticulocyte lysate system (Promega), by adding 40 mCi of [ 35 S]methionine (Amersham) in a total volume of 50 ml. The translated product was either analysed directly by electrophoresis on SDS-7.5% polyacrylamide gel or subjected to in vitro protein ± protein binding. For in vitro binding 50 ml of 35 S-methionine-labelled HIPK2 protein were incubated with resin containing 5 mg of the GST or the GST/HMG-Y plasmids. Reactions were carried out in binding buer (150 mM NaCl, 0.1% NP40, 50 mM HEPES (pH 7.5)), 1 mM PMSF and protease inhibitors at 48C for 4 h of gentle rocking. The protein-protein complexes formed on the resin were brought down by centrifugation. The resin was washed ®ve times at 48C with 1 ml of cold binding buer. The HIPK2 protein which remained attached to the resin bound GST or GST/HMG-Y fusion protein were resolved on SDS-7.5% polyacrylamide gel; the gel was dried, and autoradiographed.
Cell culture, transfections, colony assay
Human embryonal kidney 293T cells were cultured in Dulbecco's Modi®ed Eagle's Medium (DMEM) supplemented with 10% foetal calf serum (GIBCO ± BRL, Life Technologies, Gaithersburg, MD, USA). PC Cl 3 is a thyroid epithelial cell line derived from 18-month-old Fischer rats. They were maintained in Coon's modi®ed F12 medium (GIBCO ± BRL) supplemented with 5% calf serum (GIB-CO ± BRL) and six growth factors as described elsewhere . The 3T3-L1 pre-adipocytic cells were a gift of Dr E Santos (National Cancer Institute, NIH, Bethesda, MD, USA), and were cultured in DMEM supplemented with 10% calf serum. The human thyroid carcinoma cell line ARO has been described (Chiappetta et al., 1995) . They were grown in DMEM plus 10% foetal calf serum. DNA was transfected by the calcium phosphate procedure as described previously (Graham and Van der Eb, 1973) . For colony assay, cells were seeded at a density of 0.5610 6 per 10-mm dish. The next day, cells were transfected with pCEFL-HA, pCEFL-HA/HIPK2 in a sense and antisense orientation, and 48 h later, cells were selected in G418 (Life Technologies). After about 15 days, cells were stained with 500 mg/ml of crystal violet in 20% methanol, and the resulting colonies were counted.
Immunoprecipitation and kinase assay
For immunoprecipitation experiments, total proteins from cells were lysed in a buer containing 50 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES, pH 7.5), 1% (v/v) Triton X-100, 50 mM NaCl, 5 mM EGTA, 50 mM sodium¯uoride, 20 mM sodium pyrophosphate, 1 mM sodium vanadate, 2 mM PMSF and 0.2 mg each of aprotinin and leupeptin per ml. Lysates were clari®ed by centrifugation at 12 000 r.p.m. for 15 min, and the supernatant was stored at 7708C; 500 mg of cell lysates were used for immunoprecipitation. Protein concentration was estimated by a modi®ed Bradford assay (Bio-Rad). The antibodies used for immunoprecipitation and Western blotting were: anti-FLAG monoclonal antibodies (Sigma); anti-HA 12CA5 mouse monoclonal antibodies (Boehringer Mannheim); the 4G10 anti phospho-Tyr monoclonal antibody was purchased from Upstate Biotechnology; the antibodies directed against the HMGI(Y) proteins are described elsewhere . The antibodies against ciclyn D3, cyclin B1 and cyclin A were from Santa Cruz Biotechnology Inc. Anti g-tubulin (Santa Cruz Biotechnology Inc) was used to equalize the amount of proteins loaded. Also membrane-staining with Red Ponceau demonstrated equal loading of protein lysates. For co-immunoprecipitation experiments, antigens and antibodies were incubated for 3 h before the addition of protein A-sepharose beads (Pharmacia Biotech). After another hour, the beads were collected and washed ®ve times with lysis buer, and boiled in Laemmli sample buer for immunoblotting analysis. The protein extracts and the immunoprecipitated pellets were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS ± PAGE) and transferred to Immobilon-P Transfer membranes (Millipore). Membranes were blocked with 5% nonfat milk proteins and incubated with antibodies at the appropriate dilutions. Bound antibodies were detected by the horseradish peroxidase-conjugated secondary antibodies followed by enhanced chemiluminescence (Amersham). In the catalytic kinase assay, immunoprecipitation pellets were incubated with 10 mg of myelin basic protein (MBP) or GST and GST/HMG-Y recombinant proteins and 10 mCi of [ 32 P]ATP in 20 ml of kinase buer (25 mM HEPES pH 7.5, 10 mM MgCl 2 , 0.1 mM sodium vanadate, 1 mM dithiothreitol for 30 min at 308C). Reactions were stopped by adding 20 ml of 26Laemmli sample buer, and the products were analysed directly by SDS ± PAGE and autoradiography.
Flow-cytometric analysis pFLAG and pFLAG-HIPK2 transfected PC Cl 3 and 293T cells analysed for DNA content as previously described (Krishan, 1975) . Cells were collected and washed in PBS. DNA was stained with propidium iodide (50 mg/ml and analysed with FACScan¯ow cytometer (Becton Dickinson, San Jose, CA, USA) interfaced with a Hewlett Packard computer (Palo Alto, CA, USA). Cell cycle data analysis was performed by CELL-FIT program (Becton Dickinson).
5'-bromo-3'-deoxyuridine incorporation
Transfection of 5610
5 cells was performed with the pFLAG or pFLAG-HIPK2 constructs. Twenty-four hours later, 5'-bromo-3'-deoxyuridine incorporation (BrdU) was added to the culture medium to a ®nal concentration of 10 mM and allowed to react for 1 h. Detection of eukaryotic green uorescent protein (fEGFP) and BrdU was performed as described (Motokura et al., 1992) . A 5'-bromo-3'-deoxyuridine Labeling and Detection Kit from Boehringer Mannheim was used to identify S phase cells.
